(Q40605504)

22 September 2017

title

The neutralization of pseudorabies virus by anti-alpha-galactocyl natural antibody in normal serum (English)

1 reference

22 September 2017

Sunao Hayashi

1

1 reference

22 September 2017

Seiji Ogawa

series ordinal

2

1 reference

22 September 2017

Yasuhiro Takashima

series ordinal

3

1 reference

22 September 2017

Haruki Otsuka

series ordinal

4

1 reference

22 September 2017

publication date

1 January 2004

1 reference

22 September 2017

1 reference

22 September 2017

volume

99

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

1-7

1 reference

Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

A unique natural human IgG antibody with anti-alpha-galactosyl specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Xenotransplantation. Cloned pigs may help overcome rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis--state of the art, June 1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Masking and reduction of the Galactose-alpha1,3-Galactose (alpha-Gal) epitope, the major xenoantigen in swine, by the glycosyltransferase gene transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

An approach to the control of disease transmission in pig-to-human xenotransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Production of alpha 1,3-galactosyltransferase-deficient pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Productive infection of a mink cell line with porcine endogenous retroviruses (PERVs) but lack of transmission to minks in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Bovine herpesvirus-1 (BHV-1) recombinant expressing pseudorabies virus (PrV) glycoproteins B and C induces type 1 immune response in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Neutralizing determinants of canine herpesvirus as defined by monoclonal antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

Characterization of pseudorabies virus glycoprotein gII expressed by recombinant baculovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2003.09.008

10.1016/J.VIRUSRES.2003.09.008

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference